Table 1.

Clinical Demographics.

Case	Age *	Sex	BMI +	Race	LVAD Type	Status of Therapy	HF Etiology	Antiplatelet, mg Daily ~	Anticoagulation ~	DM #	HTN #
1	59	M	37.5	Black	HM2	DT	NICM	Aspirin, 325 mg	Warfarin	Y	Y
2	56	M	27.1	Black	HM3	DT	NICM	Aspirin, 81 mg	Warfarin	N	N
3	56	M	31.6	White	HM3	DT	ICM	Aspirin, 81 mg	Warfarin	N	Y
4	75	M	24	White	HM3	DT	NICM	Aspirin 325 mg	Warfarin	N	Y
5	50	M	37.4	White	HM3	DT	NICM	Aspirin, 81 mg	Warfarin	N	Y
6	63	M	48.9	Black	HW	DT	NICM	None	None	Y	Y
7	47	M	44.6	Black	HW	DT	NICM	None	Warfarin	N	Y
8	51	M	34	Black	HW	DT	NICM	None	Warfarin	Y	Y
9	50	M	22.6	Black	HW	BTT	NICM	Aspirin, 325 mg	Warfarin	N	Y
10	43	M	26.4	White	HW	BTT	ICM	Aspirin, 325 mg	Warfarin	Y	Y
11	53	F	35.9	White	HW	BTT	NICM	Aspirin, 325 mg	Warfarin	N	Y

* Age at diagnosis, ⁺ BMI denoted as kg/m², DM diabetes, HF denotes heart failure, HTN hypertension, NICM non-ischemic cardiomyopathy, ICM ischemic cardiomyopathy, BTT bridge to transplant, DT destination therapy. ^~ reported on home medication list at time of diagnosis, ^# defined as problem listed as diagnosis with corresponding medication.